Purchase Order 75F40126P00266
Award Date 9/14/26
Potential Completion Date 9/16/26
Potential Value $75K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Food and Drug Administration issued a purchase order to The Food And Drug Law Institute, Inc. for $18,360 on July 21, 2026, to cover registration and attendance at the FDLI Enforcement, Litigation, and Compliance Conference. Performance occurs in Washington, DC. The order is firm fixed price with a completion date of December 11, 2026.</p>
- <p>The Food and Drug Administration issued a purchase order to the National Academy of Sciences on September 18, 2024, valued at $100,000.00, for FDA support to the NASEM Leadership Consortium. The order is firm fixed price with no set-aside designation. Performance takes place in Washington, DC 20418. Ultimate completion is scheduled for September 29, 2025.</p>
- <p>The Food and Drug Administration awarded a purchase order to Regulatory Affairs Professionals Society for $88,356.00 on September 15, 2026. The order covers RAPS Convergence 2026, with an ultimate completion date of September 17, 2026. Work is performed in Charlotte, North Carolina. Pricing is firm fixed price with no small business set-aside applied.</p>
- <p>The Food and Drug Administration awarded a $173,975 definitive contract to Emory University for Executive Order 14398 compliance work on September 6, 2026, under firm fixed-price pricing with no set-aside.</p> <p>Place of performance is Silver Spring, Maryland. The contract runs through September 5, 2027. The source does not specify the originating solicitation scope or detailed deliverables beyond the EO 14398 reference.</p>
- <p>The Food and Drug Administration issued a delivery order to E-Paga, Inc., a minority-owned small business, on September 6, 2023, with a ceiling value of $733,635.34 for bringing a nonprescription drug to market.</p> <p>The order is issued under the General Services Administration's Multiple Award Schedule (MAS). Place of performance is Rockville, MD. The period of performance extends through November 21, 2027. Pricing is time and materials. No set-aside applies to this delivery order.</p>
- <p>The Food and Drug Administration issued a $309,073.26 delivery order to Integrated Behavioral Health, Inc. on September 28, 2026, for post-marketing prescription drug abuse surveillance data under Executive Order 14398.</p> <p>Place of performance is Silver Spring, Maryland. The order is firm fixed price with an ultimate completion date of September 27, 2027.</p>
- <p>The Food and Drug Administration issued a purchase order to Biotechnology Innovation Organization on June 22, 2026, valued at $24,400 for the 2026 Biotechnology Innovation Organization (BIO) Convention. No set-aside applies. Work is performed in Silver Spring, Maryland. The order is firm fixed price with an ultimate completion date of July 16, 2026.</p>
- <p>The Food and Drug Administration awarded a purchase order to the University of North Carolina at Chapel Hill for $70,140.12 on September 20, 2024, to acquire subject matter expertise for evaluating the effect of obesity on the pharmacokinetics and pharmacodynamics of monoclonal antibodies in pediatric patients as part of the FY26 UDO Initiative. Performance occurs in Silver Spring, Maryland. The order carries a firm fixed price structure and concludes on September 29, 2026.</p>
- <p>The Food and Drug Administration issued a $541,187 delivery order to Eastern Research Group Inc. on September 24, 2025, for updating inputs to the FDA Labeling and Reformulation Cost Models, with a firm fixed-price structure and ultimate completion date of March 28, 2028.</p> <p>Place of performance is Concord, MA. The order carries no set-aside designation.</p>
- The Food and Drug Administration issued a $380,540 delivery order to Molecular Epidemiology Inc., a woman-owned small business, on September 1, 2026, for microbial survey of FDA-regulated foods, agricultural water, and cosmetics. The order is issued under an FDA IDIQ contract for microbiological analysis services. Place of performance is Berwyn Heights, MD. The order is firm fixed price with an ultimate completion date of August 31, 2028. No set-aside was used for this delivery order.
The Food and Drug Administration issued a purchase order to Parenteral Drug Association, Inc. for $74,916.00 on September 14, 2026, to support the Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference 2026 under Executive Order 14398. Place of performance is Washington, DC. The order carries a firm fixed price structure with an ultimate completion date of September 16, 2026. No small business set-aside applies.
Generated 9/4/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.9k | 9/2/26 |